Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000032:analysis / Q000378:metabolism; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology*; D008032:Limbic System / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D009778:Occipital Lobe / Q000032:analysis; D010648:Phenylacetates / Q000032:analysis; D011817:Rabbits; D014149:Tranquilizing Agents / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000494:pharmacology*
D010648:Phenylacetates; D014149:Tranquilizing Agents; D014282:Trihexyphenidyl; D006220:Haloperidol; D000109:Acetylcholine; D004298:Dopamine